Chemokines in rheumatoid arthritis

Springer Seminars in Immunopathology

Volumn 20, Issue 1-2, 1998, Pages 115-132

  Szekanecz, Zoltan ^a,d   Strieter, Robert M ^b   Kunkel, Steven L ^b   Koch, Alisa E ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CHEMOKINE; CHEMOKINE RECEPTOR; CORTICOSTEROID; DEXAMETHASONE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PLATELET DERIVED GROWTH FACTOR; RANTES; THIOMALATE SODIUM; TIAPROFENIC ACID;

ARTICLE; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; CHEMOKINES; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; HUMANS; INTERLEUKIN-8; PEPTIDES; RECEPTORS, CHEMOKINE; SYNOVIAL FLUID; SYNOVITIS;

EID: 0031727432     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00832002     Document Type: Article

References (76)

1. Akahoshi T, Wada C, Endo H, Hirota K, Hosaka S, Takagishi K (1993) Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Arthritis Rheum 36 : 762
2. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ (1997) A new class of membrane bound chemokine with a CXC3 motif. Nature 385 : 640
3. Bedard PA, Golds EE (1993) Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts. J Cell Physiol 154 : 433
4. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K, Feldmann K (1990) Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 20 : 2141
5. Castor CW, Smith EM, Hossler PA, Bignall MC, Aaron BP (1992) Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture. Arthritis Rheum 35 : 783
6. Castor CW, Andrews PC, Swartz RD, Ellis SG, Hossler PA, Clark MR (1993) The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease. Arthritis Rheum 36 : 1142
7. Chen Y, Davidson BL, Marks RM (1994) Adenovirus-mediated transduction of the interleukin 8 gene into synoviocytes. Arthritis Rheum 37 : S304
8. De Gendt CM, De Clerck LS, Bridts CH, Van Osselaer N, Stevens WJ (1996) Relationship between interleukin-8 and neutrophil adhesion molecules in rheumatoid arthritis. Rheumatol Int 16 : 169
9. Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, Matsushima K, Stengaard-Pedersen K (1994) Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol 23 : 2
10. Drevlow BE, Lovis R, Hang R, Haag MA, Sinacore JM, Jacobs C, Blosche C, Landay A, Moreland LW, Pope RM (1996) Recombinant human interleukin-1 receptor type 1 in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum 39 : 257
11. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K (1991) Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 10 : 245
12. Evans CH, Robbins PD (1996) Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 8 : 230
13. Evans CH, Robbins PD (1997) Gene therapy in rheumatology. Rheumatol Eur 26 |Suppl 2| : 65
14. Fahey TJ III, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires T (1991) Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 148 : 2764
15. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14 : 397
16. Feldmann M, Elliott MJ, Woody JN, Maini RN (1997) Anti-tumor necrosis factor-α therapy of rheumatoid arthritis. Adv Immunol 64 : 283
17. Golds EE, Mason P, Nyirkos P (1989) Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not beta 2-microglobulin in human synovial cells and fibroblasts. Biochem J 259 : 585
18. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-1pr mouse model. J Exp Med 186 : 131
19. Hachicha M, Rathanaswami P, Schall TJ, McColl SR (1993) Production of monocyte chemotactic protein-1 in human type B synoviocytes. Arthritis Rheum 36 : 26
20. Harris ED (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 332 : 1277
21. Hogan M, Sherry B, Ritchlin C, Fabre M, Winchester R, Cerami A, Bucala R (1994) Differential expression of the small inducible cytokines groα and groβ by synovial fibroblasts in chronic arthritis: possible role in growth regulation. Cytokine 6 : 61
22. Hosaka S, Akahoshi T, Wada C, Kondo H (1994) Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 97 : 451
23. Isik FF, Rand RP, Gruss JS, Benjamin D, Alpers CE (1996) Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res 61 : 71
24. Jordan NJ, Watson ML, Yoshimura T, Westwick J (1996) Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts. Br J Pharmacol 117 : 1245
25. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95 : 2868
26. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Strieter RM (1991) Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 147 : 2187
27. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM (1992) Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 90 : 772
28. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 : 1798
29. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM (1994) Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 93 : 921
30. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Strieter RM (1994) Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest 94 : 1012
31. Koch AE, Kunkel SL, Shah MR, Fu R, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM (1995) Macrophage inflammatory protein-1 beta: a C-C chemokine in osteoarthritis. Clin Immunol Immunopathol 77 : 307
32. Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, Burdick MD, Pope RM, Strieter RM (1995) Growth related gene product alpha: a chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 155 : 3660
33. Koch AE, Kunkel SL, Strieter RM (1995) Cytokines in rheumatoid arthritis. J Invest Med 43 : 28
34. Koch AE, Kunkel SL, Strieter RM (1996) Chemokines in arthritis. In: Koch AE, Strieter RM (eds) Chemokines in disease. RG Landes Company, Austin, pp 103-116
35. Kunkel SL, Lukacs N, Kasama T. Strieter RM (1996) The role of Chemokines in inflammatory joint disease. J Leukoc Biol 58 : 6
36. Lebsack ME, Paul CC, Bloedow DC (1991) Subcutaneous IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 34 : S45
37. Loetscher P, Dewald B, Baggiolini M, Seitz M (1994) Monocyte chemoattractant protein 1 and interleukin 8 production hy rheumatoid synoviocytes: effects of anti-rheumatic drugs. Cytokine 6 : 162
38. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer JM (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391 : 344
39. Lotz M, Terkeltaub R, Villiger PM (1991) Cartilage and joint inflammation: regulation of IL-8 expression by human articular chondrocytes. J Immunol 148 : 466
40. Mackay CR (1997) Chemokines: what chemokine is that ? Curr Biol 7 : R384
41. Martin CA, Dorf ME (1991) Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 135 : 245
42. Moreland LW, Baumgartner SW, Schiff MH, Tindall KA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-fusion protein. N Engl J Med 337 : 141
43. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, Itoh Y, Ikanoue T (1997) Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 158 : 5536
44. Ogata H, Takeya M, Yoshimura T, Takagi K, Takahashi K (1997) The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J Pathol 182 : 106
45. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene "intererine" cytokine family. Annu Rev Immunol 9 : 617
46. Piechl P, Ceska M, Effenberger F, Haberhauer G, Broell H, Lindley IJ (1991) Presence of NAP-1/1L-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 34 : 333
47. Piechl P, Ceska M, Broell H, Effenberger F, Lindley IJ (1992) Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann Rheum Dis 51 : 19
48. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells with a homing predilection for certain inflammatory sites. J Clin Invest 101 : 746
49. Rampart M, Herman AG, Grillet B, Opdenakker G, Van Damme J (1992) Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease. Lab Invest 66 : 512
50. Rankin ECC, Choy EHS, Kassimos D, Kingsley GH, Sopwith AM, Isenberg DA, Panayi GS (1995) The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol 34 : 334
51. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR (1993) Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 268 : 5834
52. Rathanaswami P, Hachicha M, Wong WL, Schall TJ, McColl SR (1993) Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis Rheum 36 : 1295
53. Recklies AD, Golds EE (1992) Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum 35 : 1510
54. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN (1995) Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 101 : 398
55. Rot A, Hub E, Middleton J, Pons F, Rabeck C, Thierer K, Wintle J, Wolff B, Zsak M, Dukor P (1996) Some aspectos of IL-8 pathophysiology. III. Chemokine interaction with endothelial cells. J Leukoc Biol 59 : 39
56. Sato M, Miyazaki T, Nagaya T, Murata Y, Ida N, Maeda K, Seo H (1996) Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J Rheumatol 23 : 432
57. Schall TJ (1991) Biology of the RANTES/SIS cytokine family. Cytokine 3 : 165
58. Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 : 669
59. Schonbeck U, Brandt E, Petersen F, Flad HD, Loppnow H (1995) IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 154 : 2375
60. Seitz M, Dewald B, Gerber N, Baggiolini M (1991) Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 87 : 463
61. Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Baggiolini M, Gerber NJ (1995) Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 34 : 602
62. Strieter RM, Polvcrini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S-Y, Roczniak S, Shanafelt AB (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270 : 27348
63. Strieter RM, Kunkel SL, Shanafelt AB, Arenberg DA, Koch AE, Polverini PJ (1996) The role of C-X-C chemokines in the regulation of angiogenesis. In: Koch AE. Strieter RM (eds) Chemokines in disease. RG Landes Company. Austin, pp 195-209
64. Tanabe M, Ochi T, Tomita T, Suzuki R, Sakata T, Shimaoka Y, Nakagawa S, Ono K (1994) Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow scrum of patients with rheumatoid arthritis. J Rheumatol 21 : 830
65. Taub DD (1996) C-C chemokines - an overview. In: Koch AE, Strieter RM (eds) Chemokines in disease. RG Landes Company, Austin, pp 27-54
66. + T cells in response to MIP-1β and MIP-1β. Science 260 : 355
67. Unemori EN, Amento EP, Bauer EA (1993) Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts. Regulation by C-X-C but not C-C cytokines. J Biol Chem 268 : 1338
68. Villiger PM, Terkeltaub R, Lotz, M (1992) Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. J Clin Invest 90 : 488
69. Villiger PM, Terkeltaub R, Lotz M (1992) Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 149 : 722
70. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM (1991) Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin K. J Exp Med 174 : 1355
71. Walz A, Kunkel SL, Strieter RM (1996) C-X-C chemokines - an overview. In: Koch AE, Strieter RM (eds) Chemokines in disease. RG Landes Company, Austin, pp 1-25
72. Watson ML, Lewis GP, Westwick J (1988) Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1 treated human synovial cell cultures. Immunology 65 : 567
73. Watson ML, Lewis GP, Westwick J (1989) PMN stimulation hy factors from IL-1 treated human synovial cell cultures. Agents Actions 27 : 448
74. Wolpe SD, Cerami A (1989) Macrophage inflammatory proteins 1 and 2: members of a novel super-family of cytokines. FASEB J 3 : 2565
75. Wooley PH, Schaefer C, Whalen JD, Dutcher JA, Counts DF (1997) A peptide sequence from platelet factor 4 (CT-112) is effective in the treatment of type II collagen induced arthritis in mice. J Rheumatol 24 : 890
76. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR, Roberts-Thomson PJ, Ahern MJ, Smith MD (1997) Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis Rheum 40 : 1400